F de Vathaire

Summary

Affiliation: Institut Gustave Roussy
Country: France

Publications

  1. ncbi Cancer mortality after radiotherapy for a skin hemangioma during childhood
    Marie Gabrielle Dondon
    INSERM U605, Institut Gustave Roussy, rue Camille Desmoulins, Villejuif 94805, France
    Radiother Oncol 72:87-93. 2004
  2. doi The carcinogenic effects of radioiodine therapy for thyroid carcinoma
    Florent de Vathaire
    Unit of Cancer Epidemiology Unit 605 of the National Institute for Health and Medical Research INSERM, Villejuif, France
    Nat Clin Pract Endocrinol Metab 4:180-1. 2008
  3. doi Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer
    Markhaba Tukenova
    L Institut National de la Santé et de la Recherche Médicale, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Oncol 28:1308-15. 2010
  4. pmc Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment
    C Rubino
    , Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Br J Cancer 89:840-6. 2003
  5. pmc Second primary malignancies in thyroid cancer patients
    C Rubino
    Unite INSERM XUR521, Gustave Roussy Institute, 39 rue Camille Desmoulins, Villejuif 94 805, France
    Br J Cancer 89:1638-44. 2003
  6. ncbi Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974
    F de Vathaire
    Institut National de la Sante et de la Recherche Medicale, Villejuif, Institut Gustave Roussy, France
    Cancer Causes Control 11:59-63. 2000
  7. ncbi Thyroid carcinomas after irradiation for a first cancer during childhood
    F de Vathaire
    Cancer Epidemiology Research Unit, National Institute for Health and Medical Research, Villejuif, France
    Arch Intern Med 159:2713-9. 1999
  8. pmc Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumour
    F de Vathaire
    , Villejuif, France
    Br J Cancer 65:425-8. 1992
  9. pmc Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment
    F de Vathaire
    Research Unit of Cancer Epidemiology U351 INSERM, Institut Gustave Roussy, Villejuif, France
    Br J Cancer 79:1884-93. 1999
  10. pmc Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood
    F de Vathaire
    , Institut Gustave Roussy, Villejuf, France
    Br J Cancer 59:792-6. 1989

Detail Information

Publications63

  1. ncbi Cancer mortality after radiotherapy for a skin hemangioma during childhood
    Marie Gabrielle Dondon
    INSERM U605, Institut Gustave Roussy, rue Camille Desmoulins, Villejuif 94805, France
    Radiother Oncol 72:87-93. 2004
    ..A cohort study was performed as part of a European Radiation Protection Program to investigate the carcinogenic effect of treatment with ionizing radiation in early childhood. This paper presents mortality after radiotherapy in this cohort...
  2. doi The carcinogenic effects of radioiodine therapy for thyroid carcinoma
    Florent de Vathaire
    Unit of Cancer Epidemiology Unit 605 of the National Institute for Health and Medical Research INSERM, Villejuif, France
    Nat Clin Pract Endocrinol Metab 4:180-1. 2008
  3. doi Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer
    Markhaba Tukenova
    L Institut National de la Santé et de la Recherche Médicale, Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Oncol 28:1308-15. 2010
    ..The purpose of this study was to assess the role of treatment in long-term overall and cardiovascular mortality after childhood cancer...
  4. pmc Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment
    C Rubino
    , Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Br J Cancer 89:840-6. 2003
    ..This relationship was limited to endometrial cancers and did not modify the relationship with radiation dose. Our results suggest that high radiation doses slightly increase the risk of second malignancies after breast cancer...
  5. pmc Second primary malignancies in thyroid cancer patients
    C Rubino
    Unite INSERM XUR521, Gustave Roussy Institute, 39 rue Camille Desmoulins, Villejuif 94 805, France
    Br J Cancer 89:1638-44. 2003
    ..These results strongly highlight the necessity to delineate the indications of (131)I treatment in thyroid cancer patients in order to restrict its use to patients in whom clinical benefits are expected...
  6. ncbi Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974
    F de Vathaire
    Institut National de la Sante et de la Recherche Medicale, Villejuif, Institut Gustave Roussy, France
    Cancer Causes Control 11:59-63. 2000
    ..Between 1966 and 1974, France performed 41 atmospheric nuclear weapon tests in the Mururoa and Fangataufa atolls in French Polynesia...
  7. ncbi Thyroid carcinomas after irradiation for a first cancer during childhood
    F de Vathaire
    Cancer Epidemiology Research Unit, National Institute for Health and Medical Research, Villejuif, France
    Arch Intern Med 159:2713-9. 1999
    ..The thyroid gland is among the most radiosensitive organs. However, little is known about the long-term risk of developing a thyroid tumor after fractionated external radiotherapy for cancer during childhood...
  8. pmc Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumour
    F de Vathaire
    , Villejuif, France
    Br J Cancer 65:425-8. 1992
    ..This result suggests that there is a common mechanism for the occurrence of neuroblastoma and of differentiated thyroid tumour...
  9. pmc Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment
    F de Vathaire
    Research Unit of Cancer Epidemiology U351 INSERM, Institut Gustave Roussy, Villejuif, France
    Br J Cancer 79:1884-93. 1999
    ..When compared with radiotherapy alone, the addition of chemotherapy increases the risk of solid SMN after a first cancer in childhood, but does not significantly modify the variation of this risk during the time after the first cancer...
  10. pmc Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood
    F de Vathaire
    , Institut Gustave Roussy, Villejuf, France
    Br J Cancer 59:792-6. 1989
    ..This study suggests that the oncogenic effect of radiations might be increased by chemotherapy, and that the combination of the two treatment modalities might be one of the major factors responsible for overall risk of SMN...
  11. ncbi Risk of melanoma following adulthood cancer: a case-control study
    A Dupuy
    National Institute of Public Health and Medical Research U605, Villejuif, France
    Eur J Cancer 41:2904-10. 2005
    ..The risk associated with chemotherapy should justify the implementation of skin surveillance for early detection of melanoma in these patients...
  12. ncbi Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment
    Carole Rubino
    Unit of Cancer Epidemiology, National Institute of Health and Medical Research U605 INSERM, Villejuif, France
    Breast Cancer Res Treat 89:277-88. 2005
    ..To quantify the risk of soft tissue and bone sarcomas after breast cancer according to the doses and technical modalities of irradiation...
  13. doi Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999
    Aurore Allard
    INSERM Unit 605, Villejuif, France
    Int J Radiat Oncol Biol Phys 78:1474-82. 2010
    ..The purpose of this study was to estimate the risk of secondary leukemia as a function of radiation dose, taking into account heterogeneous radiation dose distribution...
  14. pmc Cancer mortality in French Polynesia between 1984 and 1992
    F de Vathaire
    National Institute of Health and of Medical Research INSERM, Unit 351, Institut Gustave Roussy, Villejuif, France
    Br J Cancer 74:1680-1. 1996
    ..A study of cancer incidence is planned...
  15. pmc Leukaemias and cancers following iodine-131 administration for thyroid cancer
    F de Vathaire
    National Institute of Health and of Medical Research, Unit 351, Institut Gustave Roussy, Villejuif, France
    Br J Cancer 75:734-9. 1997
    ..When digestive tract cancers were excluded, the overall excess relative risk of second cancer per estimated effective sievert received to the whole body was -0.2 (P = 0.6)...
  16. ncbi Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment
    Carole Rubino
    Unit of Cancer Epidemiology, National Institute of Health and Medical Research U521 INSERM, Institut Gustave Roussy, Villejuif, France
    Breast Cancer Res Treat 75:15-24. 2002
    ..10) per gray delivered to the site of lung cancer was evidenced. Our results agree with previous studies in favor of an increased risk of lung cancer after radiation therapy for breast cancer...
  17. ncbi Radiation dose as a risk factor for malignant melanoma following childhood cancer
    S Guerin
    National Institute of Public Health and Medical Research INSERM XR521, IGR, 39 rue Camille Desmoulins, 94805 Cedex, Villejuif, France
    Eur J Cancer 39:2379-86. 2003
    ..In conclusion, radiotherapy may contribute to an increased risk of melanoma as a SMN, but only at very high doses of low linear energy transfer radiation. Common genetic origins between gonadal tumours and malignant melanomas are likely...
  18. pmc Thyroid cancer following nuclear tests in French Polynesia
    F de Vathaire
    Radiation Epidemiology Group, U1018 Inserm, Institut Gustave Roussy, 39 rue Camille Desmoulins, INSERM, Villejuif F 94800, France
    Br J Cancer 103:1115-21. 2010
    ..Between 1966 and 1974, France conducted 41 atmospheric nuclear tests in Polynesia, but their potential health effects have not previously been investigated...
  19. ncbi Long-term risk of sarcoma following radiation treatment for breast cancer
    A Taghian
    Department of Radiation Therapy, Institut Gustave Roussy, Villejuif, France
    Int J Radiat Oncol Biol Phys 21:361-7. 1991
    ....
  20. ncbi Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment
    Carole Rubino
    Research Unit of Cancer Epidemiology XU521 INSERM, Institut Gustave Roussy, Villejuif, France
    Int J Cancer 107:791-6. 2003
    ..For these patients, many more years of follow-up are required to appreciate their overall risks of treatment-related SMNs...
  21. ncbi [131 iodine: medical use. Carcinogenic and genetic effects]
    M Schlumberger
    Institut Gustave Roussy, Villejuif
    Ann Endocrinol (Paris) 57:166-76. 1996
    ..These data indicate that there is no scientific reason to avoid the use of 131I even in young patients when therapeutic benefits can be obtained...
  22. ncbi Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer
    Laurence Guldner
    National Institute of Health and Medical Research INSERM, Institut Gustave Roussy, Villejuif, France
    Radiother Oncol 81:47-56. 2006
    ..To determine the cardiac status in children 15 years (yrs) or more after a solid tumour treatment...
  23. ncbi Characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort
    Carole Rubino
    Unit of Cancer Epidemiology, National Institute of Health and Medical Research U521 INSERM, Villejuif, France
    Thyroid 12:299-304. 2002
    ..1-6.5), and conversely the frequency of follicular histology was similar in male cases and in male controls (OR = 0.3, 95% CI: 0.1-1.4). The risks of recurrence and of thyroid cancer related death were similar in cases and in controls...
  24. ncbi Malignant breast tumors after radiotherapy for a first cancer during childhood
    Catherine Guibout
    National Institute of Health and Medical Research, Cancer Epidemiology Research Unit U605 INSERM, Physics Department, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif, France
    J Clin Oncol 23:197-204. 2005
    ..To assess the specific role of treatment and type of first cancer (FC) in the risk of long-term subsequent breast cancer (BC) among childhood cancer survivors...
  25. ncbi Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens
    Vita Ridola
    Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France
    Eur J Cancer 45:814-8. 2009
    ..This study aimed at comparing gonadal toxicity of ifosfamide versus cyclophosphamide received during childhood...
  26. ncbi [Thyroid cancer following exposure to ionising radiation]
    M Schlumberger
    Institut de Cancerologie Gustave Roussy, 114 rue Edouard Vaillant, Villejuif Cedex, France
    Cancer Radiother 15:394-9. 2011
    ..In case of contamination with radioiodines, administration of potassium iodide can prevent thyroid irradiation...
  27. doi Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer
    Ibrahima Diallo
    U605 Institut National de la Santé et de la Recherche Médicale, Villejuif, France
    Int J Radiat Oncol Biol Phys 74:876-83. 2009
    ....
  28. doi Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields
    France Nguyen
    INSERM U 605, Villejuif, France Institut Gustave Roussy, Villejuif Cedex, France
    Int J Radiat Oncol Biol Phys 70:908-15. 2008
    ..To take into account the heterogeneity of the dose distribution so as to evaluate the overall risk of an SMN after a childhood cancer, we therefore focused on the integral dose restricted to the irradiated fields...
  29. ncbi Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study
    Sylvie Guerin
    L Institut National de la Santé et de la Recherche Médicale, Villejuif, France
    J Clin Oncol 25:2833-9. 2007
    ..The aim of this study was to investigate the independent role of the FMN in the onset of any SMN...
  30. doi Long-term mortality from second malignant neoplasms in 5-year survivors of solid childhood tumors: temporal pattern of risk according to type of treatment
    Markhaba Tukenova
    Radiation Epidemiology Group, CESP Centre for research in Epidemiology and Population Health, U1018, INSERM, Villejuif, France
    Cancer Epidemiol Biomarkers Prev 19:707-15. 2010
    ..The temporal pattern in mortality from late second malignant neoplasms in solid childhood cancer survivors, according to the type of treatment, has not been investigated in detail...
  31. doi Cancer mortality among French nuclear contract workers
    Sylvie Guerin
    Unit 605, INSERM, Villejuif, France
    Am J Ind Med 52:916-25. 2009
    ..Nuclear workers from French contracting companies have received higher doses than workers from Electricité de France (EDF) or Commissariat à l'Energie Atomique (CEA)...
  32. ncbi Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer
    Marie Cecile Le Deley
    Biostatistics and Epidemiology Unit, Department of Medicine, Institut Gustave Roussy, Villejuif, France
    J Clin Oncol 25:292-300. 2007
    ..To determine the risk factors for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) after breast cancer...
  33. doi Long-term mortality in a cohort study of 6,800 French breast cancer patients treated between 1954 and 1983
    Houda Boukheris
    National Institute of Health and Medical Research, Villejuif, France
    Acta Oncol 47:1122-32. 2008
    ..To investigate the impact of initial tumour characteristics and loco-regional radiotherapy on long-term survival following breast cancer diagnosis...
  34. doi Thyroid adenomas and carcinomas following radiotherapy for a hemangioma during infancy
    Nadia Haddy
    INSERM, U605, Villejuif, France
    Radiother Oncol 93:377-82. 2009
    ..This paper presents the incidence of differentiated thyroid adenomas and carcinomas after radiotherapy in this cohort...
  35. ncbi Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study
    Sylvie Guerin
    National Institute of Public Health and Medical Research INSERM, Unit 605, Villejuif, France
    Int J Cancer 120:96-102. 2007
    ..3 (95%CI, 1.1-4.8). Radiation was found to be the foremost treatment-related risk factor for the occurrence of a SMN. Compared to sequential treatment, concomitant chemo-radiotherapy may lead to a higher risk of a SMN...
  36. ncbi The risk of multiple primary breast and thyroid carcinomas
    Elisabeth Adjadj
    Unit of Cancer Epidemiology, National Institute of Health and Medical Research, Gustave Roussy Institute, Villejuif, France
    Cancer 98:1309-17. 2003
    ....
  37. ncbi Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique
    Marie Cecile Le Deley
    Biostatistics and Epidemiology Unit, the Radiophysics Unit, the Department of Pediatric Oncology, the Cytogenetics Laboratory, Institut Gustave Roussy, Villejuif, France
    J Clin Oncol 21:1074-81. 2003
    ..To estimate the risk of secondary leukemia as a function of the dose of epipodophyllotoxins and anthracyclines...
  38. ncbi [Cardiac toxicity of cancer treatment regimes in children and adolescents: physiopathology, clinical data and the paediatric oncologist's point of view]
    Francois Pein
    Département d Oncologie de l Enfant et l Adolescent, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif
    Bull Cancer 91:185-91. 2004
    ..Other cytotoxic drugs such as high-dose cyclophosphamide, amsacrin, 5-FU and tubulin acting agents are also mentioned as a result of their cardiac toxicity, but this is not usually dose-cumulative...
  39. doi Long-term evaluation of Ifosfamide-related nephrotoxicity in children
    Odile Oberlin
    Pediatrics and Biostatistics Departments, and l Institut National de la Santé et de la Recherche Médicale, Institut Gustave Roussy, Villejuif, France
    J Clin Oncol 27:5350-5. 2009
    ..Ifosfamide is widely used in pediatric oncology but its nephrotoxicity may become a significant issue in survivors. This study is aimed at evaluating the incidence of late renal toxicity of ifosfamide and its risk factors...
  40. ncbi Thyroid cancer after radiation exposure
    C Rubino
    INSERM U 521 and Department of Nuclear Medicine and Endocrine Tumors, Institut Gustave Roussy, 94805 Villejuif, France
    Eur J Cancer 38:645-7. 2002
  41. ncbi Cancer mortality during the 1968-1994 period in a mining area in France
    M G Dondon
    INSERM U605, Institut Gustave Roussy, 39, rue Camille Desmoulins, 94805 Villejuif, France
    Eur J Cancer Prev 14:297-301. 2005
    ..We concluded that the excess of cancer deaths could not be exclusively due to potential professional exposures among the workers of the mining complex and are probably explained by environmental contamination...
  42. pmc Leukaemia mortality in French communes (administrative units) with a large and rapid population increase
    A Laplanche
    Department of Biostatistics and Epidemiology, Institut Gustave Roussy, Villejuif, France
    Br J Cancer 69:110-3. 1994
    ..0 expected from national mortality statistics. There was no difference in the risk of leukaemia mortality according to sex, age, size of the population increase or region (Ile de France versus others)...
  43. doi Thyroid volume measurement in external beam radiotherapy patients using CT imaging: correlation with clinical and anthropometric characteristics
    C Veres
    INSERM, CESP Centre for research in Epidemiology and Population Health, U1018, Radiation Epidemiology Team, F 94807, Villejuif, France
    Phys Med Biol 55:N507-19. 2010
    ....
  44. pmc Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy
    F Pein
    Department of Paediatric Oncology, Institut Gustave Roussy, rue Camille Desmoulins 39, 94805 Villejuif, France
    Br J Cancer 91:37-44. 2004
    ..The risk increases with the dose of adriamycin and radiation received to the heart, without evidence for threshold...
  45. ncbi Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy
    C Durante
    Institut Gustave Roussy, 94805 Villejuif Cedex, France
    J Clin Endocrinol Metab 91:2892-9. 2006
    ..The goal of this study was to estimate the cumulative activity of (131)I to be administered to patients with distant metastases from thyroid carcinoma...
  46. pmc Long-term risk of second malignant neoplasm after a cancer in childhood
    F de Vathaire
    , Institut Gustave Roussy, Villejuif, France
    Br J Cancer 59:448-52. 1989
    ..The risk of cancer increased with age in the reference population and increased faster in the cohort, because the standardised incidence ratio is constant over a long period...
  47. doi Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies
    Jerome Philippe Garsi
    INSERM U605, Villejuif, France
    J Nucl Med 49:845-52. 2008
    ....
  48. ncbi Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study
    Pauline Brindel
    Unit 605, INSERM, Villejuif, France
    Am J Epidemiol 167:219-29. 2008
    ..This study confirms the role of menstrual and reproductive factors in the risk of differentiated thyroid cancer in Pacific island populations...
  49. doi Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers
    Mihaela Achille
    Laboratoire de Radiobiologie et Oncologie, DSV DRR Commissariat à l Energie Atomique, Villejuif, France
    Am J Clin Oncol 32:1-8. 2009
    ..To better define the biologic profile of radiation-induced and sporadic PTC, we compared in these two groups of PTC the expression of cell cycle regulatory proteins and telomere length...
  50. doi Individual radiation therapy patient whole-body phantoms for peripheral dose evaluations: method and specific software
    I Alziar
    U605 INSERM, Villejuif, France IFR69, Villejuif, France Université Paris XI, Villejuif, France Institut Gustave Roussy, Villejuif, France
    Phys Med Biol 54:N375-83. 2009
    ..Although present results are preliminary and our research is ongoing, they appear encouraging, since such patient-adjusted phantoms are crucial in the optimization of radiation protection of patients and for follow-up studies...
  51. pmc Potential therapeutic role of cisplatinum in autologous bone marrow transplantation: in vitro eradication of neuroblastoma cells from bone marrow
    L Bettan Renaud
    , Institut Gustave Roussy, Villejuif, France
    Br J Cancer 60:529-32. 1989
    ..Results indicate that cisplatinum exhibits a high and specific tumoricidal property and appears to be valid in bone marrow purging...
  52. doi Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study
    Pauline Brindel
    INSERM Unit 605, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Cancer Causes Control 20:581-90. 2009
    ....
  53. ncbi Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification
    Melania Pulcrano
    Nuclear Medicine and Endocrine Oncology, Commissariat à l Energie Atomique LRC29V, Institut Gustave Roussy and University Paris Sud, Villejuif, France
    Thyroid 17:639-46. 2007
    ....
  54. ncbi Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France
    Taraneh Shojaei-Brosseau
    Unité de Recherches en Epidémiologie des Cancers INSERM U521, Institut Gustave Roussy, Villejuif Cedex, France
    Pediatr Blood Cancer 42:99-105. 2004
    ..The aim of this study was to estimate the fraction of inherited cases and penetrance associated with a carrier status, and to investigate the hypothesis that susceptibility cancer genes might be non-specific...
  55. ncbi Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: a population-based case-control study in the five Nordic countries
    Gudrun Svahn-Tapper
    Department of Radiation Physics, University Hospital, Lund, Sweden
    Acta Oncol 45:438-48. 2006
    ..However, in combination with radiotherapy, chemotherapy showed a significant potentiating effect. Relapse was found to be an independent risk factor for development of an SMST, with a higher relative risk for females than for males...
  56. ncbi Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood
    Nadia Haddy
    National Institute of Public Health and Medical Research INSERM Unit 605, Institut Gustave Roussy, rue Camille Desmoulins, 94805 Villejuif, France
    Eur J Cancer 42:2757-64. 2006
    ..Our results suggest that the long-term risk of secondary leukaemia could be higher than previously reported...
  57. ncbi Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma
    Carole Rubino
    National Institute of Public Health and Medical Research, INSERM, Unit 605, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    Int J Radiat Oncol Biol Phys 62:1084-9. 2005
    ..The aim of this study in thyroid cancer patients was to evaluate the role of familial factors in the risk of colorectal cancer and their potential interaction with radioiodine exposure...
  58. ncbi Childhood malignancies in French Polynesia during the 1985-1995 period
    Cécile Challeton De Vathaire
    Institut de Radioprotection et de Surete Nucleaire, Le Vesinet, France
    Trop Med Int Health 9:1005-11. 2004
    ..The incidence of acute non-lymphocytic leukaemia (ANLL) decreased from 3.3 x 10(-5) between 1985 and 1989, an unexpectedly high incidence, to 0.8 x 10(-5) between 1990 and 1995...
  59. ncbi Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood
    Axelle Menu-Branthomme
    National Institute of Public Health and Medical Research, Unit XUR521, Gustave Roussy Institute, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France
    Int J Cancer 110:87-93. 2004
    ..A closer surveillance of children treated with this treatment combination is strongly recommended...
  60. pmc Reconstruction of individual radiation doses for a case-control study of thyroid cancer in French Polynesia
    Vladimir Drozdovitch
    International Agency for Research on Cancer, 150, cours Albert Thomas, Lyon, Cedex 08, F 69372, France
    Health Phys 94:418-33. 2008
    ..A thorough compilation of the results of all radiation monitoring that was performed in French Polynesia in 1966-1974 would be likely to greatly improve the reliability and the precision of the dose estimates...
  61. ncbi Potential funding crisis for the Radiation Effects Research Foundation
    Mark P Little
    Department of Epidemiology and Public Health, Imperial College Faculty of Medicine, London W2 1PG, UK
    Lancet 364:557-8. 2004
  62. ncbi Funding crisis at the Radiation Effects Research Foundation
    Mark P Little
    J Radiol Prot 24:195-7. 2004
  63. ncbi Efficacy and tolerability of hyaluronan (ialuset) in the treatment of pressure ulcers: a multicentre, non-randomised, pilot study
    Brigitte Barrois
    Service de médecine physique et réadaptation, Centre Hospitalier de Gonesse, Gonesse, France
    Drugs R D 8:267-73. 2007
    ..However, no clinical trials of hyaluronan as a treatment option for pressure ulcers have been reported as yet...